As such, determination of the true contribution of CYP2E1-mediated ROS formation and effects on the subsequent development of alcoholic liver disease (ALD) has been based on the use of CYP2E1 specific antibodies, knockdowns and CYP2E1 transgenic animals. This evidence concerns the gene CYP2E1 and alcoholic liver diseases.